• Current Research on Biosciences and Biotechnology

    The Current Research on Biosciences and Biotechnology (CRBB) encourages researchers to publish works related to the use of the biosciences and biotechnology in understanding the world around us. From Health and Medicine to Advanced Materials, these state-of-the-art research offer novel insights in a multidisciplinary environment.

    READ MORE
  • Bandung Food and Health Conference and Expo 2019

    Celebrating 100 Years of Bandung Institute of Technology

    Lean More

The Current Research on Biosciences and Biotechnology journal aims to be a leading publication for state-of-the-art research in the biosciences, from Health and Medicine to Biotechnology to Advanced Materials.

Editor-in-Chief

Assoc. Prof. Dr. Elfahmi, M.Si., Apt. (School of Pharmacy, Bandung Institute of Technology, Indonesia)

Editorial Board

Prof. Dr. Ibrahim Jantan (Department of Pharmacy, Faculty of Allied Health Sciences, Universiti Kebangsaan Malaysia)

Prof. Dr. Khairurrijal, M.Si. (Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology, Indonesia)

Prof. Dr. Normah Mohd Noor (Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia)

Prof. Dr. I Nyoman Pugeg Aryantha, Ph.D. (School of Life Sciences and Technology, Bandung Institute of Technology, Indonesia)

Prof. Dr. Mohammed Shoeb (Department of Chemistry, University of Dhaka, Bangladesh)

Prof. Dr. I. Sahidin, S.Pd., M.Si. (Faculty of Pharmacy, Halu Oleo University, Indonesia)

Prof. Dr. Muhammad Iqbal Choudary (International Center for Chemical and Biological Sciences, University of Karachi, Pakistan)

Prof. Ikuro Abe, Ph.D (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan)

Prof. Dr. Maike Petersen (Institute of Pharmaceutical Biology and Biotechnology, Philipps-University Marburg, Germany)

Prof. Dr. Dra. Berna Elya, Apt., M.Si. (Department of Pharmacy, University of Indonesia)

Dr. Ernawati Arifin Giri-Rachman (School of Life Sciences and Technology, Bandung Institute of Technology, Indonesia)

Dr. Dessy Natalia (Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology, Indonesia)

Dr. Fenny Martha Dwivany (School of Life Sciences & Technology, Bandung Institute of Technology, Indonesia)

Dr. Debbie Soefie Retnoningrum, Apt. (School of Pharmacy, Bandung Institute of Technology, Indonesia)

Managing Editor

Dr. Husna Nugrahapraja (School of Life Sciences and Technology, Bandung Institute of Technology, Indonesia)

Dr.rer.nat. Agus Cahyadi (School of Pharmacy, Bandung Institute of Technology, Indonesia)

Hubbi Nashrullah Muhammad, M.Si. (School of Pharmacy, Bandung Institute of Technology, Indonesia)

Web Manager

Sandy Akbar Nusantara (Biosciences and Biotechnology Research Center, Bandung Institute of Technology)

Given drug discovery timelines and irrespective of technological innovations in the pipeline, it seems likely that [biopharmaceutical] approvals over the next few years will continue to be dominated by mAb-based products and by products synthesized using conventional expression systems and administered by means of conventional parenteral delivery.